• 검색 결과가 없습니다.

Dosimetric comparison of coplanar and non-coplanar volumetric-modulated arc therapy in head and neck cancer treated with radiotherapy

N/A
N/A
Protected

Academic year: 2021

Share "Dosimetric comparison of coplanar and non-coplanar volumetric-modulated arc therapy in head and neck cancer treated with radiotherapy"

Copied!
10
0
0

로드 중.... (전체 텍스트 보기)

전체 글

Loading

수치

Table 1.  Patients characteristics
Fig. 1.  The typical beam arrangements of coplanar VMAT plan (A) and non-coplanar VMAT plan (B) for an example case with a dose color wash
Table 2.  Summary of the quantitative analysis of DVH of the target volumes for the two techniques
Fig. 2.  Summary of the average values of volume encompassed by the low doses in the healthy body tissues for all the cases: (A) non-coplanar  VMAT (ncVMAT) and coplanar VMAT (cVMAT) treatment plans for sequential based Phase I and (B) ncVMAT and cVMAT tre
+2

참조

관련 문서

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable

Patients with breast cancer; ovarian cancer; renal cell carcinoma; pancreatic neuroendocrine cancer; colorectal cancer; head and neck cancer; non-small cell lung

Preoperative evaluation of pelvic lateral lymph node of patients with lower rectal cancer: comparison study of MR imaging and CT in 53 patients?.

Results: 44 of 1048 patients with gastric cancer(4.1%) had synchronous and metachronous cancers. The average time interval between gastric cancer and secondary primary cancer

Concentration-Dependent inhibition of cell viability by adenosine in human oral fibroblast and FaDu human head and neck squamous cell carcinoma · · ·

For patients treated for chin augmentation using either genioplasty with Medpor Ⓡ or osteotomy, the predictive value of the correlation of the hard and

 Although van der Waals equation is still less accurate at high

Although visceral fat adiposity has known to be associated with clinical, pathologic, and oncologic outcomes in patients with colorectal cancer (CRC), the